Pfizer’s COVID-19 vaccine may cost as low as $10 per dose in India (approximately Rs 730). This may be the lowest price for an mRNA-based jab globally, and nearly half the rate in developed markets such as the UK, US, and EU. US pharma giant Pfizer and its German partner ...
Read More »FDA Approves Aducanumab (Aduhelm) to Treat Alzheimer
The US Food and Drug Administration (FDA) has approved the anti-amyloid agent aducanumab (Eduhelm, Biogen/Christian) for the treatment of Alzheimer’s disease (AD), approving a recommendation by its own advisory panel Disregard the recommended not to give the drug. Aducanumab was approved using the accelerated approval route, which can be used ...
Read More »WHO Says, Children’s Vaccination is Not a Priority
The WHO states that vaccination of children before school is not necessary if adults who have come in contact with children have been vaccinated. Let us tell you that less than one percent of the COVID vaccines given globally have been used in poor countries. The World Health Organization’s (WHO) ...
Read More »FDA Approves Ibrexafungerp (Brexafemme) for Vaginal Yeast Infection
The US Food and Drug Administration (FDA) has approved ibrexafungerp tablets (Brexafem) as a 1-day oral therapy for vaginal yeast infections, it is estimated that 3 out of every 4 women face at least once in their life. Ibrexafungerp is the first drug approved in a new antifungal class for ...
Read More »FDA Approves Ozanimod (Zeposia) to Treat Ulcerative Colitis
The US Food and Drug Administration (FDA) has approved ozanimod (Zeposia) for adults who suffer from moderate to active ulcerative colitis (UC), the company announced. Ozanimod’s approval for UC is based on data from True North, a phase 3 placebo-controlled trial that evaluated medication in 645 adults (mean age, 42 ...
Read More »Pfizer Testing Pneumococcal Vaccine with COVID-19 Booster Shot
Pfizer said, the purpose of the study is to understand whether the combination of vaccines is safe, and the immune response after adding the pneumonia vaccine to the existing COVID-19 vaccine. WORLD – Pfizer Inc. said on Monday that it began testing fully vaccinated adults over 65 years of age ...
Read More »FDA Approved Rybrevant to Treat Non-Small Cell Lung Cancer
WHO – The US Food and Drug Administration (FDA) approved Rybrevant (Amivanthamb-vmjw) on 21 May, as the primary treatment for adult patients with non-small cell lung cancer, whose tumors have specific types of genetic mutations: epidermal growth factor receptor (EGFR) ) Exon 20 insertion mutation. The FDA also approved Guardant360 ...
Read More »COVID-19 Vaccine Protects from all Know Variants: WHO Says
WORLD – World Health Organization (WHO) official says that COVID-19 vaccines authorized for use in the United States and Europe provide protection against all known coronavirus variants. WHO European Regional Director Hans Kluge said at a press conference on Thursday, “All COVID-19 virus variants that have emerged so far do ...
Read More »Taiwan: Covid-19 Cases are Increasing, Struggling with Vaccine Shortage
Taiwan is troubled by the second wave of coronavirus infection. Especially in the capital Taipei, there has been a steady increase in the number of newly infected people in the last week. On Monday, this number reached 335. On Sunday, 207 new cases were reported. In view of this, many ...
Read More »Small increase in new COVID-19 cases observed in children
According to a report by the American Academy of Pediatrics and Children’s Hospital Association, after declining for 2 consecutive weeks, the number of new COVID-19 cases in children increased slightly. This increase was less than 0.6% – 72,067 cases reported during the week of 30 April to 6 May, compared ...
Read More »
Reports Stack News and Updates